Gastroenterology
Gastroenterology practices and GI platforms providing endoscopy, hepatology, and digestive disease management.
- 4
- Verticals
Overview
Gastroenterology practices and GI platforms provide endoscopy, hepatology, and digestive-disease management. It is among the hottest specialty roll-ups, driven by the lucrative ancillary economics of endoscopy and ambulatory surgery centers attached to GI practices.
PE-backed GI platforms (GI Alliance, US Digestive Health, Gastro Health) have consolidated rapidly, capturing endoscopy, pathology, and infusion ancillaries. Colorectal-cancer screening volumes and an aging population support durable demand.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so gastroenterology is not separately sized.
Business model & economics
- Revenue model
- Office visits plus high-margin endoscopy and ASC ancillaries
- Recurring revenue
- Moderate — procedure- and screening-driven
- EBITDA margin
- 20–30% with ancillaries
- Capex intensity
- Moderate
- Among the hottest specialty roll-ups.
- Endoscopy and ASC ancillaries drive economics.
- Colorectal screening and aging support demand.
M&A deal context
Who’s acquiring
What’s driving deals
- Rapid GI roll-up for endoscopy/ASC ancillaries.
- Screening-volume and aging demand.
- Ancillary-driven economics.
Verticals in this segment
- 4.10.10.1GI Alliance & Platform Groups
PE-backed multi-specialty gastroenterology management organizations.
- 4.10.10.2Hospital-Based GI Programs
Gastroenterology practices employed by or affiliated with hospitals.
- 4.10.10.3Independent GI Practices
Independently-owned gastroenterology physician practices.
- 4.10.10.4Inflammatory Bowel Disease Centers
Specialized GI centers focused on Crohn's disease and ulcerative colitis.
Find Gastroenterology acquisition targets
Search Acquisera’s index for companies classified under Gastroenterology (4.10.10) and build a targeted deal pipeline.
Search companies